Tabea K.

Tabea K. worked at MorphoSys as a Manager & Clinical Biomarker Lead from August 2020 to March 2022 before being promoted to Senior Manager & Clinical Biomarker Lead in March 2022. Prior to that, Tabea K. held the role of Associate R&D Program Manager at BioNTech SE from September 2018 to August 2020.

Tabea K. has a strong educational background in the field of molecular biomedicine. Tabea obtained their Bachelor's degree in Biology, General from Westfälische Wilhelms-Universität Münster | WWU Weiterbildung gGmbH in 2013, where they graduated in the top 2% of their class. Tabea went on to pursue a Master's degree in Biotechnology from the same institution, completing it in 2015. Tabea further continued their education at the University of Münster and received a Doctor of Philosophy (PhD) degree in Molecular Biomedicine in 2018.

In addition to their academic achievements, Tabea also gained international exposure through semester abroad experiences. Tabea spent time at the Université de Lorraine in 2014 as part of a semester abroad program. In 2012, they also had the opportunity to study abroad at Universidad de Granada.

Tabea's educational journey also includes an intensive course in Business Administration and Management, General from FernUniversität in Hagen in 2017-2018. Additionally, they pursued a specialization in law, specifically in patents, trademarks, competition, and copyright, earning a qualification in "Intellectual Property" from the University of Münster in 2014-2015.

Although the provided information does not mention any obtained certifications, Tabea K. may have acquired further knowledge and skills through certifications in Industrial Pharma Management (White & Blue Belt), Process Management OMG OCEB2, Project Management PMI CAPM, and Projectleader Certificate (§ 15 GenTSV). However, no specific details regarding the institutions, months, or years of obtaining these certifications are given.